NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 3.42% |
| ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 3.31% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.25% |
| AGIO | Agios Pharm | Healthcare | Biotechnology | 2.87% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.77% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.73% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.65% |
| LXRX | Lexicon Pharmaceuticals Inc | Healthcare | Biotechnology | 2.44% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 2.37% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 2.37% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.33% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.26% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.25% |
| KNSA | Kiniksa Pharmaceuticals Ltd | Healthcare | Biotechnology | 2.21% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.12% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.07% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.07% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.05% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.04% |
| MAAC | Montes Archimedes Acquisition Corp | Financial Services | Shell Companies | 2.03% |
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.